close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

15.70 +0.24 (+1.54%)
Streaming Delayed Price Updated: 11:34 AM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
What Analysts Are Saying About Avantor Stock
 
Via Benzinga
Avantor (AVTR) Stock Trades Up, Here Is Why
Shares of life sciences company Avantor (NYSE:AVTR) jumped 2.9% in the afternoon session after Bank of America Securities maintained its "Buy" rating on the company. This followed a similar move from... 
Via StockStory
Topics Artificial Intelligence
Avantor (AVTR): Buy, Sell, or Hold Post Q2 Earnings?
Since April 2025, Avantor has been in a holding pattern, posting a small return of 2.3% while floating around $15.30. The stock also fell short of the S&P 500’s 30.6% gain during that period. 
Via StockStory
Topics Stocks
Avantor (AVTR) Stock Is Up, What You Need To Know
Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.9% in the afternoon session after sentiment towards the stock improved following a series of positive developments, including an analyst... 
Via StockStory
Topics Government
Avantor Responds To Activist Investor Engine Capital’s Letter: ‘Acting With Urgency To Strengthen Growth’
Via Stocktwits
Trump-Era Funding Cuts Add Pressure On This Life Sciences Stock — Activist Investor Eyes Sale At Up To 65% Premium
Via Stocktwits
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Avantor (NYSE:AVTR)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Avantor (NYSE:AVTR) and its peers. 
Via StockStory
Topics Economy
Deep Dive Into Avantor Stock: Analyst Perspectives (11 Ratings)
 
Via Benzinga
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
3 Cash-Producing Stocks We Keep Off Our Radar
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Why Avantor (AVTR) Stock Is Trading Lower Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 2.7% in the afternoon session after RBC Capital Markets lowered its price target on the stock to $16 from $17. 
Via StockStory
Topics Artificial Intelligence Economy
3 Healthcare Stocks with Warning Signs
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
SoFi, Warner Bros. Discovery, Avantor, Conagra, Nvidia: What Sparked Heavy After-Hours Trading In These 5 Stocks?
SoFi’s record run triggered increased activity in the stock, while underperformance proved positive for certain other names. 
Via Stocktwits
Topics Economy
1 Value Stock to Target This Week and 2 Facing Challenges
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Topics Retirement
Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Integra LifeSciences, IQVIA, Avantor, National Vision, and United Airlines Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. 
Via StockStory
Topics Economy Stocks
2 Small-Cap Stocks on Our Buy List and 1 We Avoid
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
AVTR Q2 Deep Dive: Margin Pressures Mount as Competitive Intensity Rises and Leadership Transition Looms
Life sciences company Avantor (NYSE:AVTR) reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 1.1% year on year to $1.68 billion. Its non-GAAP profit of $0.24 per... 
Via StockStory
Topics Economy
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
Why Avantor (AVTR) Stock Is Trading Up Today
Shares of life sciences company Avantor (NYSE:AVTR) jumped 6.1% in the morning session after activist investor Engine Capital disclosed it is pushing the company to explore a potential sale or make... 
Via StockStory
Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
Engine Capital, holding a 3% stake in Avantor, urges the board to pursue a turnaround or sale, citing years of underperformance, missed targets, and lost market share. 
Via Benzinga
Avantor Surges As Activist Investor Takes Aim At 'Self-Inflicted' Issues
The investor is digging in to improve years of share decline, saying the company can improve its cost discipline and turnover. 
Via Investor's Business Daily
Topics Supply Chain
Avantor Q2 Revenue Tops Estimates
Via The Motley Fool
Topics Supply Chain
Avantor: A Century of Scientific Purity and Global Impact
Avantor (NYSE: AVTR) is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology industries. Headquartered in Radnor, Pennsylvania,... 
Via MarketMinute
Topics Artificial Intelligence Emissions Initial Public Offering
Avantor Shares Plummet Amidst Broader Market Turmoil and Company-Specific Headwinds
Avantor (NYSE: AVTR) shares have recently experienced a significant and sustained plunge, hitting a 52-week low and reflecting a challenging period for the life sciences company. This sharp decline is... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure
Avantor missed Q2 EPS expectations as weak bioprocessing sales and customer disruptions pressured earnings, despite flat organic growth and a CEO change. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today